AGITG Trial News
AGITG Trial news: The AGITG currently has nineteen studies open to recruitment and three studies in... Read More
Impact Spotlight: the INTEGRATE trials
Clinical trials are constantly evolving as new insights come to light. The INTEGRATE studies are... Read More
March 2021: Research Update
First sites for INTEGRATE IIb to open soon The INTEGRATE II trial has transitioned to a INTEGRATE IIb after the study was updated to incorporate a promising new treatment. The purpose of INTEGRATE II was to determine whether regorafenib improved overall survival for people with advanced gastro-oesophageal cancer. INTEGRATE IIb... Read More
Trial impact spotlight: TACTIC
This year marks the 30th anniversary of the GI Cancer Institute and AGITG. This year, we are looking... Read More
Introducing the Australian Rare Cancer Portal
Building an online network of rare cancer clinicians and researchers to improve outcomes for patients Although there have been... Read More
Celebrating 30 years of Excellence and Innovation in GI cancer research
For 30 years, the AGITG and GI Cancer Institute have been working towards a world free from Gastro-Intestinal... Read More
Announcing the 2020 Innovation Grant recipients
Thanks to the support of our community during 2020, we are awarding $565,036 in funding for new clinical... Read More
December meeting updates
Scientific Advisory Committee meeting 4 December 2020 Innovation Fund recipients Doctor Lorraine Chantrill, AGITG Chair, announced recipients of the... Read More
Developing Research in HCC: AGITG and AstraZeneca Collaborative Meeting
In November this year, members of the AGITG leadership group held a collaborative meeting with AstraZeneca. The purpose... Read More
2020: The year in review
This year presented many challenges with the outbreak of COVID-19. However, AGITG members and supporters continued to push... Read More
AGITG Pancreatic Cancer surgical guidelines update
Many thanks to Doctor Robert Gandy for providing this summary. The Leadership Group of the AGITG Pancreatic Cancer Surgical... Read More
Life as a medical oncologist during COVID-19
Associate Professor Lara Lipton is a medical oncologist working in Melbourne. We spoke to her about the impact... Read More
Associate Professor Jeanne Tie on receiving the Best New Concept Award
Medical oncologist Associate Professor Jeanne Tie was awarded the Best New Concept Award at the New Concepts Symposium... Read More
The Consumer Advisory Panel welcomes two new members
Two new members have joined our Consumer Advisory Panel this year – oesophageal cancer survivor Geoff Parnell, and... Read More
Pancreatic cancer study is RANDOMS by name, but not by nature
Although the study dietitian Belinda Steer has developed is called RANDOMS, its impact will be anything but random.... Read More
In FORECAST-1, organoid technology predicts the best colorectal cancer treatment
There is a large unmet need for people with metastatic colorectal cancer when standard therapy fails. Professor Peter... Read More
Dr Oliver Piercey recognised for research highlighting gaps in treatment for elderly colorectal cancer patients
Medical oncologist Dr Oliver Piercey was awarded the Best Poster Award at our Annual Scientific Meeting for his... Read More
Doctor David Lau reflects on the Merck-AGITG Clinical Research Fellowship
Dr David Lau was awarded the inaugural the Merck-AGITG Clinical Research Fellowship in 2017, securing a two-year position... Read More
Professor Niall Tebbutt recognised for going above and beyond the call of duty
One of the nation’s leading medical oncologists, Professor Niall Tebbutt, has been recognised for his commitment to research... Read More
Monash Health recognised for outstanding commitment to clinical trials
Monash Health was awarded the Outstanding Site Award at the AGITG Annual Scientific Meeting on Friday 28 August... Read More